Passage Bio

PASGNASDAQ
$0.999600
0.1112.95%
At Close: -
$0.938900
-0.06-6.07%
After Hours: 9:27 AM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$13.00
Lowest Price Target1
$5.00
Consensus Price Target1
$7.00

Passage Bio (NASDAQ:PASG) Stock, Analyst Ratings, Price Targets, Predictions

Passage Bio Inc has a consensus price target of $7, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Canaccord Genuity, Canaccord Genuity, and Raymond James on May 15, 2024, March 5, 2024, and November 14, 2023. With an average price target of $10.67 between Canaccord Genuity, Canaccord Genuity, and Raymond James, there's an implied 1036.08% upside for Passage Bio Inc from these 3 analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Canaccord Genuity
Raymond James
Chardan Capital
Guggenheim
Citigroup

1calculated from analyst ratings

Analyst Ratings for Passage Bio

Buy NowGet Alert
05/15/2024Buy Now1284.6%Canaccord Genuity
Whitney Ijem
$14 → $13MaintainsBuyGet Alert
03/05/2024Buy Now1391.11%Canaccord Genuity
Whitney Ijem
→ $14ReiteratesBuy → BuyGet Alert
11/14/2023Buy Now432.54%Raymond James
Danielle Brill
$9 → $5MaintainsOutperformGet Alert
08/08/2023Buy Now858.57%Chardan Capital
Geulah Livshits
$11 → $9MaintainsBuyGet Alert
05/12/2023Buy Now858.57%Raymond James
Danielle Brill
$10 → $9MaintainsOutperformGet Alert
12/15/2022Buy Now1071.58%Chardan Capital
Geulah Livshits
$18 → $11MaintainsBuyGet Alert
11/11/2022Buy Now1071.58%Guggenheim
Debjit Chattopadhyay
$13 → $11MaintainsBuyGet Alert
11/11/2022Buy Now432.54%Citigroup
Neena Bitritto-Garg
$7 → $5MaintainsBuyGet Alert
11/08/2022Buy Now752.06%Canaccord Genuity
Whitney Ijem
→ $8Initiates → BuyGet Alert
05/17/2022Buy Now965.08%Citigroup
Neena Bitritto-Garg
$15 → $10MaintainsBuyGet Alert
05/17/2022Buy Now965.08%Raymond James
Danielle Brill
$24 → $10MaintainsOutperformGet Alert
03/08/2022Buy Now—JP Morgan
Anupam Rama
—DowngradeOverweight → NeutralGet Alert
03/04/2022Buy Now2456.18%Raymond James
Danielle Brill
$29 → $24MaintainsOutperformGet Alert
01/19/2022Buy Now539.05%Goldman Sachs
Madhu Kumar
$29 → $6DowngradeBuy → NeutralGet Alert

FAQ

Q

What is the target price for Passage Bio (PASG) stock?

A

The latest price target for Passage Bio (NASDAQ:PASG) was reported by Canaccord Genuity on May 15, 2024. The analyst firm set a price target for $13.00 expecting PASG to rise to within 12 months (a possible 1284.60% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Passage Bio (PASG)?

A

The latest analyst rating for Passage Bio (NASDAQ:PASG) was provided by Canaccord Genuity, and Passage Bio maintained their buy rating.

Q

When was the last upgrade for Passage Bio (PASG)?

A

There is no last upgrade for Passage Bio

Q

When was the last downgrade for Passage Bio (PASG)?

A

The last downgrade for Passage Bio Inc happened on March 8, 2022 when JP Morgan changed their price target from N/A to N/A for Passage Bio Inc.

Q

When is the next analyst rating going to be posted or updated for Passage Bio (PASG)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Passage Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Passage Bio was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.

Q

Is the Analyst Rating Passage Bio (PASG) correct?

A

While ratings are subjective and will change, the latest Passage Bio (PASG) rating was a maintained with a price target of $14.00 to $13.00. The current price Passage Bio (PASG) is trading at is $0.94, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch